Title |
Tech ID # |
SERCA2: Novel Target for the Treatment of Cystic Fibrosis |
09-05
|
Adenosine A2A Receptor: A Prognosis Marker for Lung Cancer |
08-11
|
Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo  |
07-07
|
Treatment with an Antibody Against VGamma4 T Cells Reduces Rheumatoid Arthritis Symptoms in Mice |
07-06
|
Knee aspirate facilitator |
07-02
|
MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo  |
06-05
|
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.) |
04-08
|
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases |
04-05
|
Method for identifying MHC-presented epitopes for T cells |
03-01
|
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancer |
02-16
|
Efficient method to produce mature neutrophils from embryonic stem cells |
02-08
|
Liposomal clodronate as a therapy for autoimmune hemolytic anemia |
02-07
|
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway |
02-05
|
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsiveness |
01-01
|
Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsiveness |
00-14
|
Cdk6 as a marker for breast cancer |
00-11
|
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs |
00-05
|
Novel molecular targets for anti-inflammatory drug development: - TALL-1: A member of the TNF gene family - TALL-1 receptor (BCMA) - TALL-1 and receptors 3D structure |
00-01
|
Method for treating inflammatory diseases using heat shock proteins |
98-07
|
Anti-CD79 antibody offers novel approach to therapy in autoimmune disease, transplantation and lymphoma |
98-04
|
Thioredoxins for the treatment of lung disease |
96-07
|
Method to Identify Compounds Regulating Actin Polymerization |
96-06
|
Peptides offer strategies for novel immunosuppressants and anti-herpes agents |
96-02
|
Promising gene immunotherapy technology fights tumors and infectious diseases |
95-03
|
Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements |
91-02
|